View More Recent Stories

Mar 6, 2025 07:00AM H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)
Mar 5, 2025 07:58AM Truist: 'WAVE Life Sciences (WVE) Remains One of Our Favorite Stocks for 2025'
Mar 4, 2025 12:08PM WAVE Life Sciences (WVE) PT Raised to $21 at JPMorgan
Mar 4, 2025 07:33AM WAVE Life Sciences (WVE) Tops Q4 EPS by 34c
Feb 25, 2025 05:04AM Jefferies Starts WAVE Life Sciences (WVE) at Buy
Feb 6, 2025 08:31AM WAVE Life Sciences (WVE) announces phase 1 of clinic trial of WVE-007
Dec 17, 2024 02:38PM WAVE Life Sciences (WVE) spreader of December 15 and 17.50 calls
Nov 30, 2024 10:00PM JPMorgan is out with its 2025 outlook for biotech stocks
Nov 12, 2024 10:31AM WAVE Life Sciences (WVE) PT Raised to $36 at Truist Securities
Oct 28, 2024 06:00AM Leerink Partners Reiterates Outperform Rating on WAVE Life Sciences (WVE)
Oct 21, 2024 06:46AM WAVE Life Sciences (WVE) PT Raised to $15 at RBC Capital
Oct 17, 2024 06:53AM H.C. Wainwright Reiterates Buy Rating on WAVE Life Sciences (WVE)
Oct 16, 2024 04:09PM Jones Trading Reiterates Buy Rating on WAVE Life Sciences (WVE)
Oct 16, 2024 08:52AM WAVE Life Sciences (WVE) Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency
Oct 3, 2024 08:17AM WAVE Life Sciences (WVE) PT Raised to $19 at B.Riley
Sep 27, 2024 03:30AM JPMorgan Reinstates WAVE Life Sciences (WVE) at Overweight
Sep 26, 2024 06:04AM WAVE Life Sciences (WVE) Prices Upsized $200M Share and Warrant Offering
Sep 25, 2024 06:55AM Mizuho Reiterates Outperform Rating on WAVE Life Sciences (WVE)
Sep 25, 2024 06:24AM B.Riley Reiterates Buy Rating on WAVE Life Sciences (WVE)
Sep 24, 2024 05:23PM WAVE Life Sciences (WVE) no longer intends to offers ordinary shares
Sep 24, 2024 04:34PM After-hours movers: KB Home, Progress Software, Worthington Industries and more
Sep 24, 2024 04:01PM WAVE Life Sciences (WVE) Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants
Sep 24, 2024 11:32AM WAVE Life Sciences (WVE) PT Raised to $22 at H.C. Wainwright
Sep 24, 2024 11:25AM Jones Trading Reiterates Buy Rating on WAVE Life Sciences (WVE)
Sep 24, 2024 07:34AM WAVE Life Sciences (WVE) Announces Positive Interim Data from FORWARD-53 Trial of WVE-N531
Sep 9, 2024 01:43AM UBS Starts LEM Holding SA (LEHN:SW) at Buy
Sep 3, 2024 12:32PM Jones Trading Reiterates Buy Rating on WAVE Life Sciences (WVE)
Aug 12, 2024 08:32AM WAVE Life Sciences (WVE) Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy
Aug 8, 2024 04:06PM Jones Trading Starts WAVE Life Sciences (WVE) at Buy
Aug 8, 2024 07:41AM WAVE Life Sciences (WVE) Misses Q2 EPS by 4c
Jun 25, 2024 01:46PM Truist Securities Defending WAVE Life Sciences (WVE): 'We're Buyers Of Weakness Today'
Jun 25, 2024 07:31AM WAVE Life Sciences (WVE) Announces Positive Results from Phase 1b/2a SELECT-HD Trial
View More Recent Stories